How to Source Lemborexant for Pharmaceutical Formulation
Lemborexant (Tablets, 5mg, 10 mg) is classified under Neurology. It is therapeutically aligned with reference brands such as Dayvigo (USA). This guide highlights key sourcing factors buyers should consider when procuring high-quality Lemborexant for formulation, R&D, or bulk manufacturing.
Product Overview:
Lemborexant is a dual orexin receptor antagonist used for treating adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. It works by competitively blocking the wake-promoting orexin receptors (OX1 and OX2), thus reducing the “wake drive” and enabling sleep. Clinical trials have shown improvements in both sleep onset latency and wake-after-sleep-onset, with maintenance of effect over up to 12 months and a favorable tolerability profile.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Lemborexant must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Lemborexant is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Lemborexant is more than procurement—it’s a strategic partnership. With its tablets form and 5mg, 10 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Lemborexant.
Frequently Asked Questions For Sourcing of Lemborexant
What is the typical lead time for Lemborexant?
Lead times range from 4–6 weeks depending on supplier and region.
Is Lemborexant available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Lemborexant require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Lemborexant?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Lemborexant?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Lemborexant?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Lemborexant suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Lemborexant be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.